scholarly journals P366 Relevance of chromogranin A according to disease activity and medical treatment in IBD patients

2014 ◽  
Vol 8 ◽  
pp. S218
Author(s):  
S. Vradelis ◽  
A. Zissimopoulos ◽  
M. Konialis ◽  
D. Chadolias ◽  
A. Bampali ◽  
...  
2020 ◽  
Vol 9 (12) ◽  
pp. R274-R285
Author(s):  
Bernardo Maia ◽  
Leandro Kasuki ◽  
Mônica R Gadelha

Acromegaly is a systemic disease associated with increased morbidity and mortality. Most of these comorbidities can be prevented or delayed with adequate disease treatment. Although three modalities of treatment (surgery, medical treatment, and radiotherapy) are available and new drugs were approved in the last decades, there are still some patients that maintain disease activity despite treatment. Therefore, there is a need for novel therapies for acromegaly and for that purpose new formulations of currently used drugs and also new drugs are currently under study. In this review, we summarize the novel therapies for acromegaly.


2014 ◽  
Vol 49 (8) ◽  
pp. 958-966 ◽  
Author(s):  
Mette Julsgaard ◽  
Mette Nørgaard ◽  
Christian Lodberg Hvas ◽  
Anne Grosen ◽  
Sara Hasseriis ◽  
...  

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Malin Backlund ◽  
Per Venge ◽  
Lillemor Berntson

Abstract Background The inflammatory process in juvenile idiopathic arthritis (JIA) involves both the innate and the adaptive immune system. The turnover and activity of neutrophil granulocytes may be reflected by proteins secreted from primary or secondary granules and from the cytoplasm of sequestered cells. Our primary aim was to compare the levels of the secondary neutrophil granule protein human neutrophil lipocalin (HNL), in JIA patients and controls, and to explore a possible priming of neutrophils through parallel analyses in plasma and serum. A secondary aim was to relate the levels of HNL to two other well-studied leukocyte proteins, S100A8/A9 and myeloperoxidase (MPO), as well as to clinical aspects of JIA. Methods The concentrations of the three biomarkers in serum, two of them also in plasma, were measured using enzyme-linked immunosorbent assay in 37 children with JIA without medical treatment, in high disease activity based on juvenile arthritis disease activity score 27 (JADAS27), 32 children on medical treatment, mainly in lower disease activity, and 16 healthy children. We assessed for differences between two groups using the Mann-Whitney U test, and used the Kruskal-Wallis test for multiple group comparisons. Spearman rank correlation, linear and multiple regression analyses were used for evaluation of associations between biomarker concentrations and clinical scores. Results The concentrations of HNL and MPO in serum were significantly increased in children with JIA (p < 0.001, p = 0.002) compared with healthy children, but we found no difference in the plasma levels of HNL and MPO between children with JIA and controls. The serum concentrations of MPO and HNL were unaffected by medical treatment, but S100A8/A9 was reduced by medical treatment and correlated with JADAS27 in both univariate (r = 0.58, p < 0.001) and multivariate (r = 0.59, p < 0.001) analyses. Conclusions Neutrophil granulocytes in children with JIA are primed to release primary and secondary granule proteins, without relation to medical treatment, whereas signs of increased turnover and sequestration of neutrophil granulocytes are reduced by treatment. Levels of neutrophil-originating proteins in serum most likely reflect underlying disease activities of JIA.


2014 ◽  
Vol 49 (3) ◽  
pp. 302-308 ◽  
Author(s):  
Mette Julsgaard ◽  
Mette Nørgaard ◽  
Christian Lodberg Hvas ◽  
Anne Grosen ◽  
Sara Hasseriis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document